Cardiovascular Business

Dare to differ: Team work, challenging vendors improves care, costs

ATLANTA—Improve quality, reduce cost. That’s often the goal, but less often the outcome. The leader of an integrated electrophysiology (EP) program shared a formula for achieving quality and savings June 13 at the Cardiovascular Service Line Symposium.

Electrophysiology & Arrhythmia

Medicare report takes aim at cardiac imaging services

A Medicare advisory panel recommended changes to Congress that included initiatives to reduce payment differences between hospital outpatient and physician office payment rates. One option targeted cardiac imaging services for a projected annual savings of $500 million.

Healthcare Economics

Cath lab alley-oop: 5 slam-dunk ways to cut cost, add value

ATLANTA—Opportunities exist within many cardiovascular programs to trim out costs and add value. But where? Suzette Jaskie, president and CEO of MedAxiom Consulting, offered five “slam dunk” approaches June 13 at the Cardiovascular Service Line Symposium in Atlanta.

Healthcare Economics

Strategic partnering: Missteps & successes

ATLANTA—Integration can have its highs and lows, even in a good relationship. Leaders from Austin Heart in Texas and St. David’s HealthCare offered an example of each June 12 at the Cardiovascular Service Line Symposium in Atlanta.

Practice Management

Standardization, structure counter healthcare chaos

ATLANTA—Healthcare systems struggle under what one strategist sees as a chaotic period of “uber-change.” One way to make progress within this mayhem is to apply standardization and structure.

Practice Management

Previous Pause Next

Bill Nye the Science Guy, still inspired and inspiring

Participatory & cozy

Duo debates $1B P4P dilemma

Lot of 2 mg warfarin tablets recalled

Structured cardiac MRI workflow is within reach

215 cardiovascular drugs under development

FDA approves St. Jude’s safety-enhanced devices

Societies go to Washington

Volumes drop but pay survives under value model

Medicare spends nearly $1B more on common lab tests than other payers